Increased effect of IMiDs by addition of cytokine-induced killer cells in multiple myeloma

Hematological Oncology
Katharina F BullokIngo G H Schmidt-Wolf

Abstract

Immunomodulatory drugs (IMiDs), such as thalidomide, lenalidomide and pomalidomide, represent the basic principle of multiple myeloma treatment. However, the development of resistance is a limiting factor. Over the last years, the efficient application of cytokine-induced killer (CIK) cells has been reported as an alternative strategy to treat hematological neoplasms. In this study, we tested for a potential synergistic effect by combining the IMiDs thalidomide, lenalidomide and pomalidomide with CIK cells in different myeloma cell lines in vitro. Myeloma cells tested with CIK cells were significantly reduced. In the combination, myeloma cells were significantly reduced compared with cells only tested with IMiDs but not to the cells tested with CIK cells. Otherwise, the number of CIK cells was significantly reduced when treated with IMiDs. Because IMiDs are active in patients with myeloma, these results lead to the expectation that combination of IMiDs and CIK cells achieve better results in the treatment of multiple myeloma compared with the single use of IMiDs. Therefore, further examinations in an in vivo setting are necessary to have a closer look on the cellular interactions. Copyright © 2015 John Wiley & Sons, Ltd.

References

Jul 1, 1991·The Journal of Experimental Medicine·I G Schmidt-WolfI L Weissman
Nov 20, 1986·Journal of Immunological Methods·D Gerlier, N Thomasset
Apr 12, 2001·The Journal of Biological Chemistry·J A KeiferA S Baldwin
Oct 29, 2004·The New England Journal of Medicine·Robert A Kyle, S Vincent Rajkumar
Jan 11, 2005·British Journal of Haematology·Toshiaki HayashiKenneth C Anderson
Jan 25, 2008·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Conor D Collins
Apr 22, 2010·Journal of Cancer Research and Clinical Oncology·C HontschaI G H Schmidt-Wolf
Jan 26, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liang LiuXiubao Ren
May 5, 2012·Cancer Biology & Therapy·Xuzhang LuBaoan Chen
Jun 26, 2012·Leukemia Research·Lenka SedlarikovaRoman Hajek
Feb 14, 2013·Experimental Hematology·Chunsheng LiuKah-Whye Peng

❮ Previous
Next ❯

Citations

Nov 7, 2017·Expert Opinion on Biological Therapy·Katalin Balassa, Vanderson Rocha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Yutaka Hattori
Expert Opinion on Investigational Drugs
Neeraj Saini, Anuj Mahindra
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Martha Q LacyS Vincent Rajkumar
Expert Opinion on Emerging Drugs
Massimo GentileFortunato Morabito
© 2021 Meta ULC. All rights reserved